Displaying 69 Switzerland Pharma companies
 Filter
City
Country
Stage
Business Model
Industry
Clear All
Export
Switzerland Pharma All business models
company score funding investors employees industries biz model city contact
BioVersys HIRING

Novel antiobiotic researcher to fight antimicrobial resistance.
46
$13M · Series C AMR Action Fund, GSK 1 to 10 Biotech, Pharma B2B Basel, Switzerland •••••••••••@bioversys.com
Anjarium Biosciences

Gene therapy research to tackle genetic diseases.
43
$59M · Series A Gimv 1 to 10 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@anjarium.com
GlycoEra

Glycanengineering platform.
39
$49M · Series A Sofinnova Partners 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@glycoera.com
Noema Pharma

Clinical-stage central nervous system (CNS) technology.
37
$110M · Series B Sofinnova Partners, Forbion Capital Partners, BioMedPartners 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@noemapharma.com
Nanolive

Platform for observing live cells in 3D without damaging them.
26
$20M Swisscom Ventures 1 to 10 Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence B2B, SaaS Lausanne, Switzerland •••••••••••@nanolive.ch
Mysthera Therapeutics

Developer of oral therapeutics to treat complex autoimmune diseases.
26
$3M · Seed Forty51 Ventures 1 to 10 Health Tech, Pharma Basel, Switzerland •••••••••••@mystheratx.com
Rejuveron Life Sciences

Biotechnology platform developing therapies by investing in people and ideas.
25
$25M · Series A 1 to 10 Health Tech, Fintech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@rejuveron.com
BC Platforms

Platform offering tools to enhance the development of personalized and precision medicine.
25
$20M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Zürich, Switzerland •••••••••••@bcplatforms.com
ImmunOs Therapeutics

Immunotherapy platform for cancer.
25
$330k · Pre Seed Lightspeed Venture Partners, Gimv, BioMedPartners 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@immunostherapeutics.com
Pharvaris

Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist.
23
$80M · Series C 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Zug, Switzerland •••••••••••@pharvaris.com
Navignostics

Platform that identifies the ideal treatment for each cancer patient’s disease.
21
$7M 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma Zürich, Switzerland •••••••••••@navignostics.com
Chord Therapeutics

Clinical-stage biopharmaceutical company developing drugs for rare diseases.
21
$16M · Series A 11 to 50 Health Tech, Biotech, Pharma B2B Geneva, Switzerland •••••••••••@chordtherapeutics.com
T3 Pharmaceuticals

Treatments that improve the lives of cancer patients with innovative approaches.
20
$26M · Series C 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B Basel, Switzerland •••••••••••@t3pharma.com
Cimeio Therapeutics

Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders.
20
$50M · Series A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Basel, Switzerland •••••••••••@cimeio.com
Flowbone

We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening
17
$166k · Pre Seed Venture Kick 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech B2B Lausanne, Switzerland •••••••••••@flowbone.com
Versameb

Platform focusing on the discovery and development of next-generation RNA-based drugs.
17
$6M · Seed 1 to 10 Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@versameb.com
NextImmune

Biotechnology company developing treatments to enhance immune system responses.
17
$154k · Pre Seed Venture Kick Health Tech, Biotech, Pharma B2B Basel, Switzerland •••••••••••@nextimmune.com
Testmate Health

Self-testing kit provider for quick, at-home medical results.
17
$1M · Seed Next Ventures 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B, B2C Lausanne, Switzerland •••••••••••@testmatehealth.com
Bloom Biorenewables Ltd

Bloom Biorenewables is making biomass a true alternative to petroleum.
14
$3M 1 to 10 Climate Tech & Green Tech, Biotech, Pharma, Energy & Nuclear, Manufacturing B2B Fribourg, Switzerland •••••••••••@bloombiorenewables.com
Molecule

Software platform that accelerates innovation in the pharmaceutical industry.
12
N/A BACKED VC, Speedinvest, BoxGroup 11 to 50 Health Tech, Fintech, Crypto & web3, Biotech, Deep Tech, Pharma B2B, Marketplace Schaffhausen, Switzerland •••••••••••@molecule.to
Galventa

Pharmaceutical manufacturing services for producing medications and therapies.
10
$807k · Seed 1 to 10 Health Tech, Biotech, Pharma, Fitness, Manufacturing, Service Industry B2B Saint Gallen, Switzerland •••••••••••@galventa.com
Actando

Learning platform for the pharma industry.
9
N/A 11 to 50 Edtech, Pharma B2B, SaaS Geneva, Switzerland •••••••••••@actando.com
Cellestia

Clinical stage R&D company developing therapies to control and modulate pathogenic gene expression.
7
N/A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Basel, Switzerland •••••••••••@cellestia.com
Mysthera Therapeutics

Developer of oral therapeutics to treat complex autoimmune diseases.
4
N/A 1 to 10 Health Tech, Pharma Basel, Switzerland •••••••••••@
NXI TherapeuticsJUST ADDED HIRING

Immunosuppressive drugs manufacturer for autoimmune diseases and transplantations.
1
$3M · Pre Seed Kickfund, Venture Kick, JFG Life Sciences Foundation 1 to 10 Biotech, Pharma B2C Basel, Switzerland •••••••••••@nxitherapeutics.com
Leman BiotechJUST ADDED HIRING

Tumor immunotherapy drug developer.
1
$7M · Seed Fuho Capital, XtalPi, Tiantu Capital 1 to 10 Biotech, Pharma B2C Lausanne, Switzerland •••••••••••@lemanbio.com
Calico BiosystemsJUST ADDED HIRING

Anti-cancer drug evaluator.
1
$167k · Pre Seed Venture Kick 1 to 10 Biotech, Pharma B2B, SaaS Lausanne, Switzerland •••••••••••@calicobiosystems.com